A detailed history of Planning Capital Management Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Planning Capital Management Corp holds 112 shares of LLY stock, worth $88,403. This represents 0.07% of its overall portfolio holdings.

Number of Shares
112
Previous 375 70.13%
Holding current value
$88,403
Previous $340 Million 70.77%
% of portfolio
0.07%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$772.14 - $960.02 $203,072 - $252,485
-263 Reduced 70.13%
112 $99.2 Million
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $32,571 - $43,575
-55 Reduced 12.79%
375 $292 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $225,831 - $266,225
430 New
430 $251 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.